ARCHIVES

Accelerated Approval Will No Longer Block Competitors, FDA Commissioner Says

This article is from The Cancer Letter archive.

Vol. 29 No. | August 12, 2003

Download PDF Visit The Full Archive

Related Articles

$1.5 Million In Direct Costs Is Proposed Core Grant Requirement

July 12, 1991

NCI Clarifies Plan For Review Of Epidemiologic Research

June 1, 2001

Public Health Service: Scientific Papers Become “Deliverables” In Own RFP

October 3, 1997

FDA Continues Bureaucratic Delays Of Cancer INDs

January 30, 1976

Executive Committee, Board of Scientific Advisors concur.

January 2, 2004

Cancer Program Depend On Vitality Of Centers, Broder ells DCPC Board

May 12, 1989